Penn professor earns 2004 award from the American College of Psychiatrists

December 29, 2004

(Philadelphia, PA) -- Dwight L. Evans, MD, the Ruth Meltzer Professor and Chairman of the Department of Psychiatry at the University of Pennsylvania School of Medicine, has earned the 2004 Award for Research in Mood Disorders from the American College of Psychiatrists. This award - which honors an individual or individual whose group has made major contributions to the understanding and treatment of mood disorders - is presented annually. Dr. Evans was chosen from among those scholars and scientific investigators who have displayed excellence in research and who are devoted to assisting people suffering from mood disorders.

Mood disorders encompass those psychiatric disorders in which a disturbance of mood is the predominant feature, including depressive, dysthymic and bipolar disorders. These disorders affect millions of people throughout the world, can be life threatening, and result in considerable suffering and disability.

According to Dr. Evans, "Depression has become the number one cause of disability within Western Europe and North America. In the United States, approximately 20 million people suffer from serious depression and close to one million people attempt suicide each year. In this country, a person dies from suicide every 18 minutes, over 30,000 deaths each year. Further research is critical to address this worldwide public health problem."

The award, which was first given in 1998, will be presented at The College's Annual Meeting in February 2005. Dr. Evans will present a featured lecture summarizing his work. The American College of Psychiatrists is a non-profit honorary association of psychiatrists who, through excellence in their chosen fields, have been recognized for their significant contributions to the profession.
-end-
Editor's Note: You may also find this news release on-line at www.uphs.upenn.edu/news.

About Penn Medicine
PENN Medicine is a $2.7 billion enterprise dedicated to the related missions of medical education, biomedical research, and high-quality patient care. PENN Medicine consists of the University of Pennsylvania School of Medicine (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System (created in 1993 as the nation's first integrated academic health system).

Penn's School of Medicine is ranked #3 in the nation for receipt of NIH research funds; and ranked #4 in the nation in U.S. News & World Report's most recent ranking of top research-oriented medical schools. Supporting 1,400 fulltime faculty and 700 students, the School of Medicine is recognized worldwide for its superior education and training of the next generation of physician-scientists and leaders of academic medicine.

Penn Health System is comprised of three hospitals (the Hospital of the University of Pennsylvania, consistently rated one of the nation's "Honor Roll" hospitals by U.S. News & World Report; Pennsylvania Hospital, the nation's first hospital and Presbyterian Medical Center); a faculty practice plan; a primary-care provider network; two multispecialty satellite facilities; and home health care and hospice.

University of Pennsylvania School of Medicine

Related Depression Articles from Brightsurf:

Children with social anxiety, maternal history of depression more likely to develop depression
Although researchers have known for decades that depression runs in families, new research from Binghamton University, State University of New York, suggests that children suffering from social anxiety may be at particular risk for depression in the future.

Depression and use of marijuana among US adults
This study examined the association of depression with cannabis use among US adults and the trends for this association from 2005 to 2016.

Maternal depression increases odds of depression in offspring, study shows
Depression in mothers during and after pregnancy increased the odds of depression in offspring during adolescence and adulthood by 70%.

Targeting depression: Researchers ID symptom-specific targets for treatment of depression
For the first time, physician-scientists at Beth Israel Deaconess Medical Center have identified two clusters of depressive symptoms that responded to two distinct neuroanatomical treatment targets in patients who underwent transcranial magnetic brain stimulation (TMS) for treatment of depression.

A biological mechanism for depression
Researchers report that in depressed individuals there are increased amounts of an unmodified structural protein, called tubulin, in lipid rafts compared with non-depressed individuals.

Depression in adults who are overweight or obese
In an analysis of primary care records of 519,513 UK adults who were overweight or obese between 2000-2016 and followed up until 2019, the incidence of new cases of depression was 92 per 10,000 people per year.

Why stress doesn't always cause depression
Rats susceptible to anhedonia, a core symptom of depression, possess more serotonin neurons after being exposed to chronic stress, but the effect can be reversed through amygdala activation, according to new research in JNeurosci.

Which comes first: Smartphone dependency or depression?
New research suggests a person's reliance on his or her smartphone predicts greater loneliness and depressive symptoms, as opposed to the other way around.

Depression breakthrough
Major depressive disorder -- referred to colloquially as the 'black dog' -- has been identified as a genetic cause for 20 distinct diseases, providing vital information to help detect and manage high rates of physical illnesses in people diagnosed with depression.

CPAP provides relief from depression
Researchers have found that continuous positive airway pressure (CPAP) treatment of obstructive sleep apnea (OSA) can improve depression symptoms in patients suffering from cardiovascular diseases.

Read More: Depression News and Depression Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.